Biltmore Family Office’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $659K | Buy |
8,349
+40
| +0.5% | +$3.23K | 0.09% | 143 |
|
|
2026
Q1 | $726K | Sell |
8,309
-460
| -5% | -$44.1K | 0.1% | 129 |
|
|
2025
Q4 | $848K | Buy |
8,769
+518
| +6% | +$50.3K | 0.12% | 110 |
|
|
2025
Q3 | $792K | Buy |
8,251
+184
| +2% | +$16.9K | 0.11% | 107 |
|
|
2025
Q2 | $709K | Buy |
8,067
+6
| +0.1% | +$509 | 0.12% | 106 |
|
|
2025
Q1 | $730K | Sell |
8,061
-60
| -0.7% | -$5.37K | 0.12% | 104 |
|
|
2024
Q4 | $654K | Sell |
8,121
-515
| -6% | -$44.6K | 0.11% | 109 |
|
|
2024
Q3 | $784K | Hold |
8,636
| – | – | 0.13% | 94 |
|
|
2024
Q2 | $686K | Buy |
8,636
+120
| +1% | +$9.84K | 0.13% | 97 |
|
|
2024
Q1 | $748K | Buy |
8,516
+84
| +1% | +$7.17K | 0.15% | 90 |
|
|
2023
Q4 | $700K | Hold |
8,432
| – | – | 0.14% | 93 |
|
|
2023
Q3 | $667K | Sell |
8,432
-125
| -1% | -$10.5K | 0.15% | 91 |
|
|
2023
Q2 | $760K | Hold |
8,557
| – | – | 0.16% | 84 |
|
|
2023
Q1 | $696K | Buy |
8,557
+125
| +1% | +$10.2K | 0.15% | 97 |
|
|
2022
Q4 | $661K | Sell |
8,432
-7
| -0.1% | -$567 | 0.14% | 99 |
|
|
2022
Q3 | $687K | Buy |
8,439
+44
| +0.5% | +$3.95K | 0.16% | 83 |
|
|
2022
Q2 | $759K | Hold |
8,395
| – | – | 0.19% | 82 |
|
|
2022
Q1 | $937K | Sell |
8,395
-1,563
| -16% | -$165K | 0.2% | 75 |
|
|
2021
Q4 | $1.04M | Buy |
9,958
+1,563
| +19% | +$181K | 0.2% | 78 |
|
|
2021
Q3 | $1.06M | Hold |
8,395
| – | – | 0.26% | 63 |
|
|
2021
Q2 | $1.05M | Sell |
8,395
-85
| -1% | -$10.7K | 0.3% | 56 |
|
|
2021
Q1 | $1.01M | Hold |
8,480
| – | – | 0.31% | 52 |
|
|
2020
Q4 | $998K | Hold |
8,480
| – | – | 0.3% | 55 |
|
|
2020
Q3 | $886K | Sell |
8,480
-1,572
| -16% | -$158K | 0.49% | 51 |
|
|
2020
Q2 | $928K | Hold |
10,052
| – | – | 0.56% | 47 |
|
|
2020
Q1 | $912K | Hold |
10,052
| – | – | 0.6% | 44 |
|
|
2019
Q4 | $1.15M | Buy |
10,052
+1,572
| +19% | +$172K | 0.46% | 59 |
|
|
2019
Q3 | $926K | Sell |
8,480
-203
| -2% | -$21.2K | 0.4% | 71 |
|
|
2019
Q2 | $846K | Sell |
8,683
-229
| -3% | -$20.9K | 0.46% | 60 |
|
|
2019
Q1 | $816K | Buy |
8,912
+395
| +5% | +$35.4K | 0.41% | 66 |
|
|
2018
Q4 | $779K | Buy |
8,517
+288
| +3% | +$26.9K | 0.44% | 67 |
|
|
2018
Q3 | $814K | Buy |
8,229
+109
| +1% | +$10.1K | 0.39% | 71 |
|
|
2018
Q2 | $695K | Sell |
8,120
-2,440
| -23% | -$204K | 0.35% | 72 |
|
|
2018
Q1 | $852K | Buy |
10,560
+1,185
| +13% | +$97.7K | 0.38% | 74 |
|
|
2017
Q4 | $761K | Buy |
+9,375
| New | +$751K | 0.34% | 77 |
|
Other funds holding MDT
Biltmore Family Office's MDT Position: Q2 2026 in Review
Biltmore Family Office increased its Medtronic (MDT) stake by 0.48% in Q2 2026, buying an estimated $3.23K and bringing the position to 8,349 shares worth $659K. The position accounts for 0.09% of the portfolio, ranked #143.
Biltmore Family Office first reported a position in MDT in Q4 2017 and has held it in 35 quarters since. The position peaked at $1.15M in Q4 2019. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Biltmore Family Office held 8,349 shares of Medtronic worth $659K as of Q2 2026.
- Biltmore Family Office bought 40 Medtronic shares in Q2 2026, an estimated $3.23K.
- Medtronic made up 0.09% of Biltmore Family Office's portfolio in Q2 2026, its #143 holding.
- Biltmore Family Office first reported a position in Medtronic in Q4 2017 and has held it in 35 quarters since.
- Biltmore Family Office's Medtronic position peaked at $1.15M in Q4 2019.
- 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Biltmore Family Office's 13F filing for Q2 2026, filed 12 Aug 2026.